Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02056743Phase 1Completed
Phase 1, randomised, open-label trial (2 arms), sponsored by Jeonbuk National University Hospital. Primary endpoints: Maximum Plasma Concentration and Area Under the Plasma Concentration Curve (AUClast). Started Sep 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02056743.